two new drugs for advanced breast cancer

Roche is introducing two new drugs for advanced breast cancer...Xeloda (capecitabine) and Herceptin (trastuzumab).

Xeloda is a prodrug of 5-FU (5-fluorouracil).

It's taken ORALLY and metabolized to 5-FU in tumour cells.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote